BSEBoard Meeting5d ago · 25 Aug 2026, 04:50 pm
Outcome of Board Meeting held on 25th August, 2026
Bacil Pharma Ltd · 524516
✦ AI SummaryMgmt Change
Bacil Pharma Ltd's Board of Directors approved the appointment of two new directors, Mr. Mahesh Singh and Mr. Anil Shiv Charan Singh, as non-executive independent directors, subject to member approval.
Analysis Scores
Earnings Impact2/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bacil Pharma Ltd - 524516 - Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th August, 2026
Attachments (1)
📄pdf
Download →
45264bd6-be73-4f4f-a9e2-0e202db4d2ef.pdf
View document text
Reg Office: G2 & G3 Samarpan Complex, Next to Mirador Hotel, Chakala, Andheri East, Mumbai – 400099
Email Id: bacilpha@yahoo.com, CIN: L24200MH1987PLC043427,
Tel: 22618452/22661541, Tel/Fax: 22618327
Date: 25th August, 2026
The Listing Department
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai – 400001
Scrip Code: 524516 | Scrip ID: BACPHAR
Subject: Outcome of Board Meeting held on 25th August, 2026
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we wish to inform you that the Board of Directors of Bacil Pharma Limited,
at its meeting held on Tuesday, 25th August, 2026, inter alia, considered and approved the
following matters:
1. Appointment of Mr. Mahesh Singh as Non-Executive Independent Director
The Board approved the appointment of Mr. Mahesh Singh (DIN: 11814569) as an Additional
Director in the capacity of Non-Executive Independent Director of the Company, subject to
the approval of the Members, wherever applicable.
2. Appointment of Mr. Anil Shiv Charan Singh as Non-Executive Director
The Board approved the appointment of Mr. Anil Shiv Charan Singh (DIN: 09338444) as an
Additional Director in the capacity of Non-Executive Director of the Company, subject to
the approval of the Members, wherever applicable.
Both the above Directors have submitted the necessary declarations and confirmations as
required under the applicable provisions of the Companies Act, 2013 and SEBI LODR
Regulations.
Further, the above Directors are not debarred from holding the office of Director by virtue of any
order of SEBI or any other regulatory authority.
The detailed disclosures as required under Regulation 30 of the SEBI LODR Regulations read
with the applicable SEBI Circular are enclosed as Annexure A.
The meeting commenced at 3:30 P.M. and concluded at 4:30 P.M.
Kindly take the above information on record.
Thanking You,
For BACIL PHARMA LIMITED
Ms. Chaitali Kalpataru Shah
Director & CFO
DIN: 11167778
Reg Office: G2 & G3 Samarpan Complex, Next to Mirador Hotel, Chakala, Andheri East, Mumbai – 400099
Email Id: bacilpha@yahoo.com, CIN: L24200MH1987PLC043427,
Tel: 22618452/22661541, Tel/Fax: 22618327
Annexure A
Details of Directors Appointed
Particulars Mr. Mahesh Singh Mr. Anil Shiv Charan Singh
Name Mr. Mahesh Singh Mr. Anil Shiv Charan Singh
Designation Additional Director – Additional Director – Non-
Independent Director Executive Director
Date of 25th August, 2026 25th August, 2026
Appointment
Term Subject to approval of Subject to approval of Members
Members
Brief Profile Mr. Mahesh Singh is a Mr. Anil Shiv Charan Singh has
professional in the trading experience in business
industry with over seven management and commercial
years of experience in product activities and possesses
sales, brand establishment and knowledge of business
business development. He operations and management. His
possesses expertise in online experience and business acumen
sales strategies and are expected to contribute to the
marketplace expansion and Company’s strategic decision-
has successfully contributed to making and business
business growth across development.
diverse product categories.
Disclosure of Not related to any Director of Not related to any Director of the
relationships the Company Company
between Directors
Debarment Not debarred from holding the Not debarred from holding the
office of Director by virtue of office of Director by virtue of any
any SEBI order or any other SEBI order or any other authority
authority
Reason for To strengthen the Board with To strengthen the Board with
Appointment experience in accounting and experience in commodity trading
financial matters and related business activities